With Approval Of HeartMate II, Thoratec Aims To Double U.S. Implant Centers
This article was originally published in The Gray Sheet
Executive Summary
Thoratec expects to double the number of U.S. centers implanting the HeartMate II continuous flowventricular assist device from 40 to 80 by the end of 2008